114 related articles for article (PubMed ID: 35830207)
21. Chemopreventive effects of pioglitazone on chemically induced lung carcinogenesis in mice.
Wang Y; James M; Wen W; Lu Y; Szabo E; Lubet RA; You M
Mol Cancer Ther; 2010 Nov; 9(11):3074-82. PubMed ID: 21045137
[TBL] [Abstract][Full Text] [Related]
22. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
[TBL] [Abstract][Full Text] [Related]
23. Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis.
Li H; Sorenson AL; Poczobutt J; Amin J; Joyal T; Sullivan T; Crossno JT; Weiser-Evans MC; Nemenoff RA
PLoS One; 2011; 6(12):e28133. PubMed ID: 22145026
[TBL] [Abstract][Full Text] [Related]
24. Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice.
Khan N; Afaq F; Kweon MH; Kim K; Mukhtar H
Cancer Res; 2007 Apr; 67(7):3475-82. PubMed ID: 17389758
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention.
Rosas RR; Nachbor KM; Handley N; Mathison G; Wuertz BR; Ba'th F; Ondrey FG
Head Neck; 2022 Mar; 44(3):661-671. PubMed ID: 34931381
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.
Prudkin L; Liu DD; Ozburn NC; Sun M; Behrens C; Tang X; Brown KC; Bekele BN; Moran C; Wistuba II
Mod Pathol; 2009 May; 22(5):668-78. PubMed ID: 19270647
[TBL] [Abstract][Full Text] [Related]
27. Detection and quantification of epithelial progenitor cell populations in human healthy and IPF lungs.
Smirnova NF; Schamberger AC; Nayakanti S; Hatz R; Behr J; Eickelberg O
Respir Res; 2016 Jul; 17(1):83. PubMed ID: 27423691
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia.
Sueoka E; Sueoka N; Goto Y; Matsuyama S; Nishimura H; Sato M; Fujimura S; Chiba H; Fujiki H
Cancer Res; 2001 Mar; 61(5):1896-902. PubMed ID: 11280744
[TBL] [Abstract][Full Text] [Related]
29. Pioglitazone prevents smoking carcinogen-induced lung tumor development in mice.
Li MY; Kong AW; Yuan H; Ma LT; Hsin MK; Wan IY; Underwood MJ; Chen GG
Curr Cancer Drug Targets; 2012 Jul; 12(6):597-606. PubMed ID: 22463586
[TBL] [Abstract][Full Text] [Related]
30. Gene Expression Profiling Revealed 2 Types of Bronchial Basal Cell Hyperplasia and Squamous Metaplasia With Different Progression Potentials.
Denisov EV; Schegoleva AA; Gerashchenko TS; Skryabin NA; Sleptcov AA; Yakushina VD; Lyapunova LS; Tuzikov SA; Pankova OV; Perelmuter VM
Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):477-483. PubMed ID: 30896548
[TBL] [Abstract][Full Text] [Related]
31. β-Catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial-mesenchymal transition.
Giangreco A; Lu L; Vickers C; Teixeira VH; Groot KR; Butler CR; Ilieva EV; George PJ; Nicholson AG; Sage EK; Watt FM; Janes SM
J Pathol; 2012 Mar; 226(4):575-87. PubMed ID: 22081448
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of PPARgamma activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo.
Al-Taie OH; Graf T; Illert B; Katzenberger T; Mörk H; Kraus MR; Barthelmes HU; Scheurlen M; Seufert J
J Gastroenterol; 2009; 44(9):919-29. PubMed ID: 19506796
[TBL] [Abstract][Full Text] [Related]
33. CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells.
Kim TW; Hong DW; Park JW; Hong SH
Br J Cancer; 2020 Dec; 123(12):1737-1748. PubMed ID: 32958825
[TBL] [Abstract][Full Text] [Related]
34. Effects of macrophage-dependent peroxisome proliferator-activated receptor γ signalling on adhesion formation after abdominal surgery in an experimental model.
Hong GS; Schwandt T; Stein K; Schneiker B; Kummer MP; Heneka MT; Kitamura K; Kalff JC; Wehner S
Br J Surg; 2015 Nov; 102(12):1506-16. PubMed ID: 26313905
[TBL] [Abstract][Full Text] [Related]
35. TGFβ can stimulate the p(38)/β-catenin/PPARγ signaling pathway to promote the EMT, invasion and migration of non-small cell lung cancer (H460 cells).
Lin LC; Hsu SL; Wu CL; Hsueh CM
Clin Exp Metastasis; 2014 Dec; 31(8):881-95. PubMed ID: 25168821
[TBL] [Abstract][Full Text] [Related]
36. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
[TBL] [Abstract][Full Text] [Related]
37. PPARγ-Mediated p21 Induction in Aerodigestive Preneoplastic Cell Lines.
Miller WA; Wuertz BR; Ondrey FG
Ann Otol Rhinol Laryngol; 2018 Oct; 127(10):677-686. PubMed ID: 30047791
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
Rusch V; Klimstra D; Linkov I; Dmitrovsky E
Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
[TBL] [Abstract][Full Text] [Related]
39. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
40. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
